. The long-term goal of Dr. Laird's laboratory is to determine the role of DNA methylation in cancer. 5-Methylcytosine DNA methylation can mediate epigenetic effects through alterations in gene expression as well as genetic effects through an increased mutation rate of 5-methylcytosine. Dr. Laird recently showed that polyp formation in the ApcMin/+mouse model could be almost completely prevented by lowering the levels of functional DNA methyltransferase (MTase) expression and thus the levels of DNA methylation. The goal of the proposed study is to elucidate the mechanism by which reduced DNA MTase levels suppress intestinal polyp formation in ApcMin/+ mice. There are four specific aims. 1) Determine whether the tumor-suppressive effect of DNA hypomethylation is restricted to intestinal neoplasia or whether it is a general characteristic of ApcMin/+ -induced tumors. He will address this by determining the effect of DNA hypomethylation of ApcMin/+ -induced tumors in the pancreas. 2) Test the hypothesis that DNA hypomethylation suppresses polyp formation by reducing the frequency of 5-methylcytosine mutation events. He will test this hypothesis using mutation assays in tissue culture and in vivo. 3) Test the hypothesis that lower levels of DNA MTase impair DNA hypermethylation of tumor-suppressor genes. He will use a novel quantitative assay to track CpG island hypermethylation in microdissected normal epithelium and adenomas from mice with different levels of DNA MTase. 4) Test the hypothesis that DNA hypomethylation suppresses intestinal polyp formation by decreasing the rate of loss of heterozygosity of the Apc gene. He proposes to use a tissue culture selection assay to determine the effect of DNA methylation on chromosome stability.
| Lee, Kwang-Ho; Oghamian, Shirley; Park, Jin-A et al. (2017) The REMOTE-control system: a system for reversible and tunable control of endogenous gene expression in mice. Nucleic Acids Res 45:12256-12269 |
| Hinoue, Toshinori; Weisenberger, Daniel J; Lange, Christopher P E et al. (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22:271-82 |
| Oghamian, Shirley; Sodir, Nicole M; Bashir, Muhammad U et al. (2011) Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice. Carcinogenesis 32:829-35 |
| Teschendorff, Andrew E; Menon, Usha; Gentry-Maharaj, Aleksandra et al. (2010) Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 20:440-6 |
| Hinoue, Toshinori; Weisenberger, Daniel J; Pan, Fei et al. (2009) Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. PLoS One 4:e8357 |
| Campan, Mihaela; Weisenberger, Daniel J; Trinh, Binh et al. (2009) MethyLight. Methods Mol Biol 507:325-37 |
| Widschwendter, Martin; Fiegl, Heidi; Egle, Daniel et al. (2007) Epigenetic stem cell signature in cancer. Nat Genet 39:157-8 |
| Chen, Hui; Xia, Meng; Lin, Mark et al. (2007) Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology 133:207-18 |
| Sodir, Nicole M; Chen, Xuan; Park, Ryan et al. (2006) Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res 66:8430-8 |
| Weisenberger, Daniel J; Siegmund, Kimberly D; Campan, Mihaela et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787-93 |
Showing the most recent 10 out of 29 publications
